Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

Also called NCT01552954

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 269 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01552954
Other papers using this trial's data
  • A low-salt diet increases the estimated net endogenous acid production in nondiabetic chronic kidney disease patients treated with angiotensin receptor blockade Nephron. Clinical practice, 2014 DOI, PubMed 25531146
  • Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants BMJ open, 2023-08-23 DOI, PubMed 37612109, PMC10450128 In the PMC Open Access subset under CC BY-NC.
  • The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial PloS one, 2015 DOI, PubMed 26098847, PMC4476682 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01552954. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-06 (actual). Results posted on 2014-12-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan
Acronym
ESPECIAL
Condition
Hypertension
Condition
Microalbuminuria
Intervention (Behavioral)
Intensive education of low salt diet
Lead sponsor
Seoul National University Bundang Hospital (class: other)
Collaborator
Daiichi Sankyo (class: industry)
Collaborator
Daewoong Pharmaceutical Co. LTD. (class: industry)

Record details

Record id
cardio:ct-nct01552954
Content hash
69506ff32560384b35e0aead821a83d237a3b53adc113961e6b8a5dac547846d